Status:
COMPLETED
Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
Lead Sponsor:
CardioFocus
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a demonstration of safety and efficacy of the ablation for pulmonary vein isolation in the treatment of paroxysmal atrial fibrillation.
Eligibility Criteria
Inclusion
- 18 to 70 years
- paroxysmal atrial fibrillation
- failure of at least one AAD
- others
Exclusion
- overall good health as established by multiple criteria
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00971204
Start Date
September 1 2009
End Date
June 1 2012
Last Update
August 1 2016
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294
2
Pacific Heart Institute
Santa Monica, California, United States, 90404
3
William Beaumont Hospital
Royal Oak, Michigan, United States, 48072
4
Mt. Sinai Hospital
New York, New York, United States, 10029